The maker of Xanax is recalling a batch of the widely prescribed anxiety medication across the United States, according to a notice published by the Food and Drug Administration (FDA).
U.S.-based pharmaceutical company Viatris Inc. is recalling Xanax, or alprazolam, because it failed to meet dissolution specifications, says the FDA report uploaded to its website this week.
That means that a drug may not be able to deliver the correct dosage over time, which could impact how the medication is absorbed into the body, or that the consistency of the batch is compromised, the FDA says on its website….